REG - Cirata PLC - Publication of Circular, Notice of GM and TVR

RNS Number : 2392K Cirata PLC 29 June 2026  

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.

29 June 2026

Cirata plc

("Cirata" or the "Company")

Publication of Circular, Notice of General Meeting and TVR

Cirata plc LSE:CRTA, announces that it has today published a circular (the "Circular") convening a general meeting of the Company (the "General Meeting") at which the Company will seek the approval of Shareholders for, inter alia,  the allotment of, and the disapplication of statutory pre-emption rights in respect of, the New Ordinary Shares to be issued following the result of the Fundraising announced on 26 June 2026 (the "Results Announcement").

As announced on 26 June 2026, the Company has raised, in aggregate, gross proceeds of approximately £5.1 million (c.$6.7 million) through the conditional placing of 17,795,610 Placing Shares (the "Placing") and the subscription for 16,359,739 Subscription Shares (the "Subscription"). In addition, the Company launched a separate retail offer via the RetailBook Platform ("Retail Offer") to raise up to approximately £0.38 million (c.$0.5 million) gross proceeds at the Issue Price. The Retail Offer closed at 8.00 a.m. on 29 June 2026 and the result of the Retail Offer was announced on 29 June 2026, with 2,155,622 Retail Offer Shares being subscribed for, raising gross proceeds of approximately £0.32 million (c.$0.43 million).

The Placing, Subscription and Retail Offer (together, the "Fundraising") are being undertaken at the Issue Price of 15.0 pence per new Ordinary Share (the "New Ordinary Shares"). A total of 36,310,971 New Ordinary Shares will be issued pursuant to the Fundraising, representing approximately 28.7 per cent. of the Existing Ordinary Shares of the Company.

The General Meeting will be held at the offices of Brown Rudnick LLP 8 Clifford Street, London, W1S 2LQ at 11.00 a.m. on 24 July 2026.

Shareholders are requested to vote as soon as possible and, in any event, to be valid so as to be received by the Registrar, MUFG Corporate Markets, by not later than 11.00 a.m. on 22 July 2026.

A copy of the Circular, including the Notice of General Meeting, is being posted to Shareholders on 29 June 2026 in accordance with Rule 20 of the AIM Rules and will shortly be available on the Company's website at www.criata.com/investors in accordance with Rule 26 of the AIM Rules.

Capitalised terms used but not defined in this announcement shall have the meanings given to them in the Circular and/or the Launch Announcement, unless the context provides otherwise.

Admission and Total Voting Rights

Completion of the Fundraising is conditional upon, inter alia, the passing of the GM Resolutions by Shareholders at the General Meeting (expected to be held at 11.00 a.m. on 24 July 2026) and Admission. Application will be made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and that dealings in the New Ordinary Shares will commence at 8.00 a.m. on 28 July 2026 (or such later time and/or date as the Joint Bookrunners and the Company may agree).

Further to the disclosure in the Launch Announcement, 500,000 of the New Ordinary Shares (representing approximately 1.4 per cent. of the New Ordinary Shares) are subject to an additional condition in relation to the establishment of a UK branch for VCT qualifying purposes which the Company expects to be satisfied by Admission.

Following Admission of the New Ordinary Shares, the Company's ordinary issued share capital will consist of 162,759,626 ordinary shares, carrying one vote each. The Company holds no ordinary shares in Treasury. Therefore, the total voting rights in the Company following Admission will be 162,759,626. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the DTRs.

For further information, please contact:

IMPORTANT INFORMATION

This announcement and the information contained herein (together the "Announcement") is for information purposes only and shall not constitute an offer to buy, sell, issue, or subscribe for, or the solicitation of an offer to buy, sell, issue, or subscribe for any securities, nor shall there be any offer, solicitation or sale of  securities in any jurisdiction in which such offer, solicitation or sale would be unauthorised or unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Any failure to comply with these restrictions may constitute a violation of the securities law of any such jurisdiction.

Certain statements contained in this Announcement constitute "forward-looking statements" with respect to the financial condition, results of operations and businesses and plans of the Company and the Group. Words such as "believes", "anticipates", "estimates", "expects", "intends", "plans", "aims", "potential", "will", "would", "could", "considered", "likely", "estimate" and variations of these words and similar future or conditional expressions, are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon future circumstances that have not occurred. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements and forecasts. As a result, the Group's actual financial condition, results of operations and business and plans may differ materially from the plans, goals and expectations expressed or implied by these forward-looking statements. No representation or warranty is made as to the achievement or reasonableness of, and no reliance should be placed on, such forward-looking statements. The forward-looking statements contained in this Announcement speak only as of the date of this Announcement. The Company, its directors, Stifel, Panmure Liberum and their respective Affiliates and any person acting on its or their behalf each expressly disclaim any obligation or undertaking to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, unless required to do so by applicable law or regulation, the FCA or the London Stock Exchange.

Each of Stifel and Panmure Liberum is authorised and regulated in the United Kingdom by the FCA and is acting exclusively for the Company and no one else in connection with the contents of this Announcement or any other matters described in this Announcement. Each of Stifel and Panmure Liberum will not regard any other person as its client in relation to the content of this Announcement or any other matters described in this Announcement and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice to any other person in relation to the content of this Announcement or any other matters referred to in this Announcement.

This Announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Stifel or Panmure Liberum or any of their respective Affiliates or any person acting on its or their behalf as to, or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

Neither the content of the Company's website (or any other website) nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this Announcement.

This Announcement has been prepared for the purposes of complying with applicable law and regulation in the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this Announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside the United Kingdom.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  MSCEKLFLQQLZBBV